Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Gothenburg, Sweden. 27 January 2026. Mölnlycke Health Care, a global leader in Medtech, headquarted in Gothenburg, Sweden, is celebrating the production of 100 million ProcedurePak® trays at the company's production sites in the Czech Republic.

This achievement reflects Mölnlycke’s commitment to more efficient and sustainable surgical care. With 100 million trays delivered, Mölnlycke has facilitated millions of procedures across the world, helping hospitals improve operating room workflows and consistency. Customised ProcedurePak trays can reduce surgical preparation time by up to 40%¹, giving healthcare teams more time to focus on patients and supporting smoother, more predictable operations.
“Reaching 100 million trays is far more than a production milestone. It represents a meaningful contribution to many millions of procedures in operating rooms worldwide. We are incredibly proud of the role we play in supporting healthcare systems and improving patient outcomes every single day,” says Fredrik Wallefors, Executive Vice President, Operating Room Solutions, Mölnlycke Health Care.
Mölnlycke’s customised ProcedurePak trays are assembled to contain all the single-use components required for a particular surgical intervention, replacing numerous individually packaged items. This tailored approach helps generate significant savings in time, cost and waste2 across both major and minor procedures.
For more information, please contact:

Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 723 757507
Mölnlycke has further strengthened its sustainability performance in the latest EcoVadis assessment, achieving a ranking in the 98th percentile.
Dartford and Gravesham NHS Trust in the UK has adopted Steriwave® nasal photodisinfection for elective orthopaedic surgery, working with Mölnlycke and Ondine Biomedical to strengthen its approach to surgical site infection prevention.
Gothenburg, Sweden. 3 November 2026. Mölnlycke® announces the appointment of Anders Andersson as Chief Executive Officer (CEO) of Mölnlycke Health Care and Fredrik Wallefors as President of Surgical, effective 1 January 2027.
Mölnlycke is partnering with DEBRA International, the world’s leading epidermolysis bullosa (EB) patient advocacy network, to deepen understanding of the needs of people living with EB and help advance wound care for the global EB community.
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
In this role, Martin will lead the joint venture's operations and growth strategy in China, with responsibility for commercial execution, organisational leadership, governance and delivery of growth ambitions in one of the world's largest wound care markets.
Mölnlycke has joined the American Limb Preservation Society (ALPS) as an official Gold Strategic Partner, reinforcing a shared commitment to improving outcomes for patients at risk of amputation due to diabetic foot complications.
At Mölnlycke Health Care, we work alongside clinicians, researchers and healthcare experts to advance evidence-based care and help raise standards for post-operative care.